Open access · CC-BY
via OpenAlex
Flavonoids and Flavonoid-Based Nanoparticles for Osteoarthritis and Rheumatoid Arthritis Management
Hicham Wahnou, Youness Limami, Mounia Oudghiri
BioChem · 2024 · ▲ 37 citations
Abstract
Arthritis, a global health burden comprising osteoarthritis and rheumatoid arthritis, demands advanced therapeutic approaches. In this context, flavonoids, a diverse group of naturally occurring compounds abundant in fruits, vegetables, and medicinal plants, have emerged as promising candidates for mitigating the inflammatory processes associated with arthritic conditions. This review aims, first, to provide a comprehensive exploration of the potential of flavonoids, focusing on specific compounds such as quercetin, epigallocatechin-3-gallate (EGCG), apigenin, luteolin, fisetin, silibinin, kaempferol, naringenin, and myricetin. The second section of this review delves into the anti-arthritic activities of these flavonoids, drawing insights from clinical trials and scientific studies. Each flavonoid is scrutinized individually to elucidate its mechanisms of action and therapeutic efficacy in the context of both osteoarthritis and rheumatoid arthritis. The third section of this review highlights the challenges associated with harnessing flavonoids for anti-inflammatory purposes. Bioavailability limitations pose a significant hurdle, prompting the exploration of innovative strategies such as the use of nanoparticles as delivery vehicles. In response to these challenges, the fourth section focuses on the emerging field of flavonoid-based nanoparticles. This includes detailed discussions on quercetin, EGCG, fisetin, and naringenin-based nanoparticles, highlighting formulation strategies and preclinical evidence supporting their potential in arthritis management. The targeted delivery to inflammatory sites and the exploration of synergistic combinations with other compounds are also discussed as promising avenues to enhance the therapeutic impact of flavonoids. This review consolidates current knowledge on flavonoids and their nanoformulations as potential therapeutic interventions for osteoarthritis and rheumatoid arthritis. By addressing challenges and presenting future research directions, this review aims to contribute to the advancement of innovative and effective strategies for alleviating the global burden of arthritis.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.3390/biochem4010003
- Canonical
- link ↗
- Fetched
- 2026-06-26 MST
Cite this
APA
Wahnou, H., Limami, Y., & Oudghiri, M. (2024). Flavonoids and Flavonoid-Based Nanoparticles for Osteoarthritis and Rheumatoid Arthritis Management. <em>BioChem</em>. https://doi.org/10.3390/biochem4010003
Vancouver
Wahnou H, Limami Y, Oudghiri M. Flavonoids and Flavonoid-Based Nanoparticles for Osteoarthritis and Rheumatoid Arthritis Management. BioChem. 2024. doi:10.3390/biochem4010003.
BibTeX
@article{hicham2024Flavon,
title = {Flavonoids and Flavonoid-Based Nanoparticles for Osteoarthritis and Rheumatoid Arthritis Management},
author = {Hicham Wahnou and Youness Limami and Mounia Oudghiri},
journal = {BioChem},
year = {2024},
doi = {10.3390/biochem4010003},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Pharmaceuticals 2023
Open access · CC-BY
Anticancer Potential of Flavonoids: An Overview with an Emphasis on Tangeretin
bioRxiv (Cold Spring Harbor Laboratory) 2024
Preprint · CC-BY
Deciphering the Timing and Impact of Life-extending Interventions: Temporal Efficacy Profiler Distinguishes Early, Midlife, and Senescence Phase Efficacies
Archives of Pharmacal Research 2025
Open access · CC-BY
Emerging concepts and challenges in the development of disease-modifying osteoarthritis drugs – a more refined perspective
Advanced science (Weinheim, Baden-Wurttemberg, Germany) 2026
Open access · OA
Integrative Approaches to Treating Cellular Senescence in Kidney Disease.
Успехи геронтологии 2025
Open access · OA
СТРУКТУРА САХАРОСНИЖАЮЩЕЙ ТЕРАПИИ КОМОРБИДНОГО ПОЖИЛОГО ПАЦИЕНТА С САХАРНЫМ ДИАБЕТОМ 2-ГО ТИПА ПО ДАННЫМ АМБУЛАТОРНОГО СПЕЦИАЛИЗИРОВАННОГО РЕГИСТРА
Nutrients 2025
Open access · CC-BY